FluWatch report: November 7 to November 13, 2021 (week 45)

Download in PDF format
(1.8 MB, 8 pages)

Organization: Public Health Agency of Canada

Published: 2021-11-19

Weekly Highlights

  • In week 45, influenza activity across Canada was low with 85% of regions reporting no influenza activity. In the past week, all influenza indicators were at low interseasonal levels. 

Virologic

  • In week 45, a total of 22 influenza detections (12 influenza A and 10 influenza B) were reported.
  • Among the 12 detections with detailed age information, all were individuals under the age of 44 years.

Syndromic

  • The percentage visits for influenza-like illness (ILI) was 2.15% in week 45.
  • The percentage of FluWatchers reporting fever and cough was 0.55% in week 45; it remains below expected levels and is stable.

Outbreaks

  • In week 45, no outbreaks were reported.
  • From August 29 to November 13, 2021 (weeks 35 to 45), 11 ILI outbreaks and no laboratory-confirmed influenza outbreaks have been reported.

Severe Outcomes

  • From August 29 to November 13, 2021 (weeks 35 to 45), no influenza-associated hospitalizations have been reported from participating provinces and territories.

On this page

Influenza/Influenza-like Illness Activity - Geographic Spread

In week 45, eight regions in four provinces (B.C., Alta., Ont., and Que.) reported sporadic influenza/ILI activity. All other surveillance regions reported no influenza/ILI activity (Figure 1).

Figure 1 - Map of influenza/ILI activity by province and territory, Canada, week 2021-45

Number of Regions Reporting in Week 45: 53 out of 53

Figure 1. Text version below.
Figure 1 - Text description
Province Influenza Surveillance Region Activity Level
N.L. Eastern No Activity
N.L. Labrador-Grenfell No Activity
N.L. Central No Activity
N.L. Western No Activity
P.E.I. Prince Edward Island No Activity
N.S. Zone 1 - Western No Activity
N.S. Zone 2 - Northern No Activity
N.S. Zone 3 - Eastern No Activity
N.S. Zone 4 - Central No Activity
N.B. Region 1 No Activity
N.B. Region 2 No Activity
N.B. Region 3 No Activity
N.B. Region 4 No Activity
N.B. Region 5 No Activity
N.B. Region 6 No Activity
N.B. Region 7 No Activity
Que. Nord-est No Activity
Que. Québec et Chaudieres-Appalaches No Activity
Que. Centre-du-Québec No Activity
Que. Montréal et Laval Sporadic
Que. Ouest-du-Québec No Activity
Que. Montérégie No Activity
Ont. Central East Sporadic
Ont. Central West Sporadic
Ont. Eastern No Activity
Ont. North East No Activity
Ont. North West No Activity
Ont. South West No Activity
Ont. Toronto Sporadic
Man. Northern Regional No Activity
Man. Prairie Mountain No Activity
Man. Interlake-Eastern No Activity
Man. Winnipeg No Activity
Man. Southern Health No Activity
Sask. North No Activity
Sask. Central No Activity
Sask. South No Activity
Alta. North Zone No Activity
Alta. Edmonton Sporadic
Alta. Central Zone No Activity
Alta. Calgary No Activity
Alta. South Zone No Activity
B.C. Interior Sporadic
B.C. Fraser Sporadic
B.C. Vancouver Coastal Sporadic
B.C. Vancouver Island No Activity
B.C. Northern No Activity
Y.T. Yukon No Activity
N.W.T. North No Activity
N.W.T. South No Activity
Nvt. Qikiqtaaluk No Activity
Nvt. Kivalliq No Activity
Nvt. Kitimeot No Activity

Laboratory-Confirmed Influenza Detections

In week 45, 22 laboratory detections of influenza were reported (12 influenza A and 10 influenza B). An additional 14 influenza detections were known to be associated with recent live attenuated influenza vaccine (LAIV) receipt and were excluded from the data as they do not represent community transmission of seasonal influenza viruses. LAIV strains are attenuated but can be recovered by nasal swab in children and adults following vaccination with that product (i.e., "shedding"). For more information, refer to the Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2021–2022 (Section IV.2).

Overall, the percentage of laboratory tests positive for influenza remains at exceptionally low levels, despite the elevated levels of testing. In week 45, 16,630 tests for influenza were performed at reporting laboratories and the percentage of tests positive for influenza was 0.13%. Compared to the past six pre-pandemic seasons (2014-2015 to 2019-2020), an average of 4,508 tests were performed for this time period, with an average of 4.6% of tests positive for influenza (Figure 3).

To date this season (August 28 to November 13, 2021), 89 influenza detections (50 influenza A and 39 influenza B) have been reported, which is lower than what we have seen historically in the past six pre-pandemic seasons, where an average of 818 influenza detections were reported at this point in the season. Excluded from these 89 influenza detections were 16 detections known to be associated LAIV receipt as they do not represent community transmission of seasonal influenza viruses, and 22 were suspected to be associated with recent LAIV receipt but were retained pending confirmation. Among subtyped influenza A detections (12), influenza A(H3N2) accounted for 83% of detections.

Detailed information on age and type/subtype has been received for 54 laboratory-confirmed influenza detections. Among the 54 detections, all were in individuals under the age of 65 (Figure 4).

Testing for influenza and other respiratory viruses has been influenced by the current COVID-19 pandemic. Changes in laboratory testing practices may affect the comparability of data to previous weeks or previous seasons.

For more detailed weekly and cumulative influenza data, see the text descriptions for Figures 2 and 3 or the Respiratory Virus Detections in Canada Report.

Figure 2 - Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, week 2021-45

Number of Laboratories Reporting in Week 45: 31 out of 34

Figure 2. Text version below.

For one province, only data from subtyped influenza A specimens are included in the weekly number of positive influenza tests in Figure 2. The number of positive tests reported in Figure 2 may not equal the total number of positive tests in the report body text.

Influenza detections known to be associated with recent LAIV receipt (N=16) are excluded from Figure 2 as they do not represent community transmission of seasonal influenza viruses.

Figure 2 - Text description
Surveillance Week A(Unsubtyped) A(H3N2) A(H1N1) Influenza B Percent Positive A Percent Positive B
35 3 0 0 0 0.0 0.0
36 1 0 0 0 0.0 0.0
37 1 3 0 0 0.0 0.0
38 0 0 0 0 0.0 0.0
39 0 0 1 0 0.0 0.0
40 0 0 0 2 0.0 0.0
41 2 1 0 3 0.0 0.0
42 1 1 1 2 0.0 0.0
43 2 1 0 3 0.0 0.0
44 1 1 0 19 0.1 0.1
45 0 0 0 0 0.0 0.0
Figure 3 - Number of influenza tests and percentage of tests positive in Canada compared to previous seasons, week 2021-45
Figure 3. Text version below.

The shaded area represents the maximum and minimum number of influenza tests or percentage of tests positive reported by week from seasons 2014-2015 to 2019-2020. Data from week 11 of the 2019-2020 season onwards are excluded from the historical comparison due to the COVID-19 pandemic.

Figure 3 - Text description
a) Number of influenza tests, 2020-2021 compared to previous seasons
Surveillance Week Number of Tests, 2021-2022 Number of Tests, 2020-2021 Maximum Number of Tests Minimum Number of Tests Average Number of Tests
35 6896 4996 1979 1311 1705
36 7686 5192 2208 1323 1707
37 8903 5335 2631 1778 2135
38 9353 6024 3039 1987 2502
39 9370 6707 3356 2365 2859
40 10493 7127 4078 2443 3134
41 10079 6817 4339 2673 3240
42 12275 6755 4649 2648 3526
43 12908 8227 4996 3084 3862
44 14810 9615 4966 2994 4020
45 16630 10748 5912 3117 4508
46 N/A 11955 5589 3176 4564
47 N/A 13103 6541 3587 5018
48 N/A 18762 7416 3569 5645
49 N/A 19649 8559 3836 6377
50 N/A 16189 9464 4017 7155
51 N/A 14059 11142 3487 8822
52 N/A 12290 11338 4272 9184
1 N/A 11681 14932 5371 12552
2 N/A 14097 16104 5315 13289
3 N/A 17002 15001 5270 11820
4 N/A 15391 15414 5873 11441
5 N/A 16607 16595 6739 11456
6 N/A 12949 16121 8324 11339
7 N/A 20727 14443 8074 10842
8 N/A 21290 14024 7606 10865
9 N/A 21891 14520 7507 10956
10 N/A 20896 17681 7005 11084
11 N/A 21220 12714 6435 9175
12 N/A 23087 10431 5976 8238
13 N/A 25811 9989 6063 7699
14 N/A 26303 8830 4773 7046
15 N/A 26284 7836 5090 6527
16 N/A 26792 6826 5000 5890
17 N/A 29154 6603 4440 5305
18 N/A 22152 5640 4143 4780
19 N/A 12725 5480 3680 4311
20 N/A 9738 5097 3046 3862
21 N/A 7442 4001 2577 3197
22 N/A 6765 3790 2424 2944
23 N/A 6341 3257 1969 2591
24 N/A 5942 3120 2034 2449
25 N/A 5774 2659 1731 2148
26 N/A 5972 2600 1573 1988
27 N/A 5213 2163 1554 1833
28 N/A 4900 2223 1451 1857
29 N/A 5122 2256 1436 1796
30 N/A 5275 1950 1463 1664
31 N/A 5398 2022 1386 1671
32 N/A 4692 1928 1269 1574
33 N/A 5616 2089 1251 1671
34 N/A 5851 2098 1374 1698
b) Percentage of tests positive for influenza, 2020-2021 compared to previous seasons
Surveillance Week Percentage of tests positive, 2021-2022 Percentage of tests positive, 2020-2021 Maximum Percentage of Tests Positive Minimum Percentage of Tests Positive Average Percentage of Tests Positive
35 0.04 0.02 1.87 0.11 0.82
36 0.01 0.00 2.28 0.30 1.13
37 0.04 0.00 1.78 0.40 0.99
38 0.00 0.02 2.35 0.55 1.30
39 0.01 0.00 2.95 0.67 1.71
40 0.02 0.00 2.33 1.08 1.70
41 0.06 0.01 3.02 1.32 1.72
42 0.05 0.00 3.40 0.87 2.18
43 0.05 0.01 5.32 0.84 2.83
44 0.25 0.07 8.55 1.20 3.70
45 0.13 0.04 10.10 1.39 4.63
46 N/A 0.03 14.11 1.51 6.05
47 N/A 0.07 15.36 1.44 7.71
48 N/A 0.05 18.20 0.84 10.61
49 N/A 0.04 19.71 1.64 13.01
50 N/A 0.01 27.02 2.36 16.82
51 N/A 0.01 29.09 3.30 20.11
52 N/A 0.00 34.54 4.28 24.48
1 N/A 0.00 31.66 5.85 23.41
2 N/A 0.00 29.10 7.06 23.01
3 N/A 0.01 30.07 12.24 23.63
4 N/A 0.00 29.45 15.89 23.96
5 N/A 0.00 30.62 19.60 24.90
6 N/A 0.02 32.39 17.89 25.00
7 N/A 0.01 32.51 16.28 25.05
8 N/A 0.00 32.87 17.45 25.14
9 N/A 0.00 34.28 16.80 24.59
10 N/A 0.00 35.99 16.05 23.22
11 N/A 0.01 31.41 16.19 21.41
12 N/A 0.00 30.03 15.03 20.10
13 N/A 0.00 28.25 14.50 19.56
14 N/A 0.00 23.16 12.66 17.86
15 N/A 0.01 20.73 11.95 16.27
16 N/A 0.00 18.52 11.64 14.48
17 N/A 0.00 17.30 9.76 12.83
18 N/A 0.00 13.02 7.88 10.26
19 N/A 0.00 11.95 4.96 8.98
20 N/A 0.01 9.13 3.19 7.22
21 N/A 0.01 7.45 2.97 5.60
22 N/A 0.00 4.96 2.19 3.86
23 N/A 0.00 4.39 0.87 2.86
24 N/A 0.02 4.36 0.81 2.25
25 N/A 0.00 3.95 0.63 1.88
26 N/A 0.00 3.08 0.69 1.81
27 N/A 0.00 2.83 0.42 1.48
28 N/A 0.00 1.84 0.41 0.91
29 N/A 0.00 1.55 0.47 1.09
30 N/A 0.04 1.46 0.46 0.90
31 N/A 0.00 1.93 0.58 1.11
32 N/A 0.00 1.19 0.52 0.92
33 N/A 0.00 1.69 0.40 0.85
34 N/A 0.02 1.57 0.42 0.92
Figure 4 - Proportion of positive influenza specimens by type or subtype and age-group reported through case-based laboratory reporting, Canada, weeks 2021-35 to 2021-45

Figure 4. Text version below.

The shaded area represents the maximum and minimum percentage of visits for ILI reported by week from seasons 2014-2015 to 2019-2020. Data from week 11 of the 2019-2020 season onwards are excluded from the historical comparison due to the COVID-19 pandemic.

Figure 4 - Text description
a) Proportion of influenza A and B by age-group
Age Group Proportion of Influenza A Proportion of Influenza B Total Number Influenza Detections
0 to 4 59,3% 40,7% 16
5 to 19 61,1% 38,9% 11
20 to 44 66,7% 33,3% 4
45 to 64 100,0% 0,0% 3
65+ 0,0% 0,0% 0
b) Proportion of subtyped influenza A(H1N1) and A(H3N2) by age-group
Age Group Proportion of A(H1N1) Proportion of A(H3N2) Total Number of Subtyped Influenza Detections
0 to 4 40,0% 60,0% 6
5 to 19 0,0% 100,0% 1
20 to 44 0,0% 100,0% 3
45 to 64 0,0% 100,0% 2
65+ 0,0% 0,0% 0

Syndromic / Influenza-like Illness Surveillance

Healthcare Practitioners Sentinel Surveillance

In week 45, 2.15% of visits to healthcare professionals were due to influenza-like illness (ILI). The sharp increase this week may be due to low number of sentinels reporting.

This indicator should be interpreted with caution as there have been changes in healthcare seeking behavior of individuals and a smaller number of sentinels reporting compared to previous seasons.

Figure 5 - Percentage of visits for ILI reported by sentinels by report week, Canada, weeks 2021-35 to 2021-45

Number of Sentinels Reporting in Week 45: 21

Figure 5. Text version below.

The shaded area represents the maximum and minimum percentage of percentage of participants reporting cough and fever by week, from seasons 2014-2015 to 2019-2020. Data from week 11 of the 2019-2020 season onwards are excluded from the historical comparison due to the COVID-19 pandemic

Figure 5 - Text description
Surveillance Week 2021-2022 2020-2021 Average Min Max
35 0.6% 0.1% 0.6% 0.4% 0.9%
36 1.2% 0.2% 0.6% 0.4% 0.9%
37 0.6% 0.4% 0.7% 0.5% 1.0%
38 0.9% 0.3% 0.7% 0.6% 1.0%
39 1.0% 0.4% 0.9% 0.5% 1.2%
40 0.5% 0.2% 1.2% 0.8% 1.7%
41 1.1% 0.4% 1.7% 0.8% 2.8%
42 1.2% 0.5% 1.6% 1.2% 2.1%
43 0.9% 0.3% 1.2% 0.8% 1.7%
44 0.6% 0.3% 1.2% 0.7% 1.7%
45 2.2% 0.4% 1.2% 0.9% 1.5%
46 N/A 0.8% 1.4% 1.2% 1.8%
47 N/A 0.3% 1.6% 1.1% 2.2%
48 N/A 0.5% 1.5% 1.1% 2.2%
49 N/A 0.5% 1.7% 1.0% 2.8%
50 N/A 0.4% 1.5% 1.1% 1.7%
51 N/A 0.5% 1.9% 1.4% 2.7%
52 N/A 0.5% 2.0% 1.0% 3.1%
1 N/A 0.7% 3.4% 1.9% 5.4%
2 N/A 0.4% 3.4% 1.8% 5.7%
3 N/A 0.2% 2.3% 1.3% 3.7%
4 N/A 0.3% 2.0% 1.1% 2.9%
5 N/A 0.2% 2.1% 1.4% 3.1%
6 N/A 0.5% 2.4% 1.4% 4.0%
7 N/A 0.3% 2.4% 0.9% 3.5%
8 N/A 0.2% 2.3% 0.8% 3.4%
9 N/A 0.2% 2.3% 0.9% 3.1%
10 N/A 0.2% 2.0% 1.0% 2.8%
11 N/A 0.2% 1.9% 1.1% 2.8%
12 N/A 0.3% 1.6% 0.6% 2.6%
13 N/A 0.4% 1.6% 1.1% 2.6%
14 N/A 0.2% 1.7% 1.1% 3.0%
15 N/A 0.3% 1.3% 0.9% 1.9%
16 N/A 0.3% 1.2% 0.8% 1.7%
17 N/A 0.4% 1.2% 0.7% 1.7%
18 N/A 0.5% 1.3% 0.5% 2.0%
19 N/A 0.3% 0.9% 0.6% 1.3%
20 N/A 0.5% 1.1% 0.6% 1.5%
21 N/A 0.3% 0.9% 0.5% 1.3%
22 N/A 0.3% 0.7% 0.3% 1.0%
23 N/A 0.2% 0.8% 0.6% 1.0%
24 N/A 0.2% 0.7% 0.6% 1.0%
25 N/A 0.2% 0.6% 0.4% 0.8%
26 N/A 0.2% 0.8% 0.5% 1.4%
27 N/A 0.3% 0.6% 0.5% 0.7%
28 N/A 0.1% 0.7% 0.5% 1.3%
29 N/A 0.3% 0.9% 0.6% 1.7%
30 N/A 0.2% 0.6% 0.2% 0.9%
31 N/A 0.2% 0.4% 0.2% 0.6%
32 N/A 0.2% 0.8% 0.3% 1.2%
33 N/A 0.3% 0.7% 0.4% 1.3%
34 N/A 0.5% 0.7% 0.4% 1.5%

FluWatchers

In week 45, 12,590 participants reported to FluWatchers, of which 0.6% reported symptoms of cough and fever (Figure 6). The reports of cough and fever are not specific to any one respiratory pathogen and can be due to influenza, or other respiratory viruses, including respiratory syncytial virus, rhinovirus, and even COVID-19. 

The percentage of participants reporting cough and fever has been stable since week 37, and remains at lower than expected levels. This may be a direct effect of individual and public health measures enacted to reduce the spread of COVID-19. FluWatchers reporting is not impacted by changes in health services or health seeking behaviours.

Among the 69 participants who reported cough and fever:

Nova Scotia had the highest participation rate this week (46 participants per 100,000 population) and the neighbourhood of K0A had the highest number of participants (140). See what is happening in your neighbourhood! Downloadable datasets are also available on Open Maps.

If you are interested in becoming a FluWatcher, sign up today.

Figure 6 - Percentage of FluWatchers reporting cough and fever, Canada, week 2021-45

Number of Participants Reporting in Week 45: 12,590

Figure 5. Text version below.

The shaded area represents the maximum and minimum percentage of percentage of participants reporting cough and fever by week, from seasons 2014-2015 to 2019-2020. Data from week 11 of the 2019-2020 season onwards are excluded from the historical comparison due to the COVID-19 pandemic

Figure 6 - Text description
Surveillance Week 2021-2022 2020-2021 Average Min Max
35 0.23% 0.22% N/A N/A N/A
36 0.28% 0.21% N/A N/A N/A
37 0.49% 0.38% N/A N/A N/A
38 0.54% 0.29% N/A N/A N/A
39 0.54% 0.45% N/A N/A N/A
40 0.58% 0.49% 2.51% 2.18% 2.71%
41 0.46% 0.44% 2.18% 1.81% 2.57%
42 0.38% 0.33% 1.80% 1.61% 2.03%
43 0.53% 0.17% 1.87% 1.49% 2.18%
44 0.51% 0.26% 1.57% 1.39% 1.78%
45 0.55% 0.29% 1.83% 1.42% 2.32%
46 0.00% 0.28% 1.83% 1.22% 2.15%
47 0.00% 0.31% 1.93% 1.44% 2.39%
48 0.00% 0.26% 2.43% 1.67% 3.35%
49 0.00% 0.17% 2.56% 1.97% 3.16%
50 0.00% 0.15% 2.91% 2.12% 3.79%
51 0.00% 0.22% 3.18% 2.53% 3.95%
52 0.00% 0.10% 3.98% 2.81% 5.38%
1 0.00% 0.12% 3.84% 2.85% 4.76%
2 0.00% 0.21% 2.94% 1.90% 3.93%
3 0.00% 0.12% 3.25% 2.35% 4.84%
4 0.00% 0.12% 3.12% 2.13% 4.23%
5 0.00% 0.17% 3.19% 2.62% 3.59%
6 0.00% 0.11% 3.47% 2.76% 4.28%
7 0.00% 0.16% 3.18% 2.58% 3.79%
8 0.00% 0.06% 3.09% 2.54% 3.65%
9 0.00% 0.10% 2.81% 2.38% 3.53%
10 0.00% 0.18% 2.58% 2.12% 3.11%
11 0.00% 0.16% 2.33% 1.89% 2.63%
12 0.00% 0.17% 2.60% 2.46% 2.82%
13 0.00% 0.17% 2.48% 1.99% 3.06%
14 0.00% 0.19% 2.13% 1.35% 2.58%
15 0.00% 0.21% 1.78% 1.60% 1.93%
16 0.00% 0.14% 2.00% 1.47% 2.44%
17 0.00% 0.22% 1.73% 1.40% 2.31%
18 0.00% 0.15% 1.50% 1.19% 2.09%
19 0.00% 0.14% N/A N/A N/A
20 0.00% 0.15% N/A N/A N/A
21 0.00% 0.09% N/A N/A N/A
22 0.00% 0.10% N/A N/A N/A
23 0.00% 0.08% N/A N/A N/A
24 0.00% 0.13% N/A N/A N/A
25 0.00% 0.12% N/A N/A N/A
26 0.00% 0.16% N/A N/A N/A
27 0.00% 0.11% N/A N/A N/A
28 0.00% 0.20% N/A N/A N/A
29 0.00% 0.20% N/A N/A N/A
30 0.00% 0.22% N/A N/A N/A
31 0.00% 0.21% N/A N/A N/A
32 0.00% 0.25% N/A N/A N/A
33 0.00% 0.31% N/A N/A N/A
34 0.00% 0.50% N/A N/A N/A

Influenza Outbreak Surveillance

In week 45, no outbreaks were reported.

To date this season (August 28 to November 13, 2021), 11 ILI outbreaks and no laboratory-confirmed influenza outbreaks have been reported. The most recent laboratory-confirmed influenza outbreak occurred in week 24 (week ending June 13, 2020) of the 2019-2020 season.

All ILI outbreaks have been reported in schools and/or daycares. The number of ILI outbreaks reported to date this season is lower than the 2020-2021 season but higher than in pre-pandemic seasons.  This is not unexpected given changes to outbreak surveillance, specifically increased vigilance in schools to monitor and report absenteeism due to ILI, and the increased restrictions on attendance for children with symptoms of viral respiratory illness.

Outbreaks of ILI are not specific to any one respiratory pathogen and can be due influenza, or other respiratory viruses, including respiratory syncytial virus, rhinovirus, and even COVID-19. Many respiratory viruses in addition to the flu commonly circulate during the fall, and can cause clusters of cases with respiratory illness which could be captured as ILI. For more information on the respiratory viruses currently circulating in Canada, please refer to the Respiratory Virus Detections in Canada.

Number of provinces and territoriesFootnote 1 reporting in week 45: 13 out of 13

Influenza Severe Outcomes Surveillance

Provincial/Territorial Influenza Hospitalizations and Deaths

In week 45, no influenza-associated hospitalizations were reported by participating provinces and territoriesFootnote 2.

To date this season (August 28 to November 13, 2021), no influenza-associated hospitalizations were reported by participating provinces and territories.

The last influenza-associated hospitalization reported by participating provinces and territories was reported in week 25 (week ending June 20, 2020) of the 2019-2020 season.

Number of provinces and territories reporting in week 45: 9 out of 9

Pediatric Influenza Hospitalizations and Deaths

In week 45, no pediatric (≤16 years of age) influenza-associated hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network.

To date this season (August 28 to November 13, 2021), no pediatric influenza-associated hospitalizations were reported by the IMPACT network.

The last pediatric influenza-associated hospitalization was reported by the IMPACT network in week 29 (week ending July 18, 2020) of the 2019-2020 season.

Adult Influenza Hospitalizations and Deaths

In week 45, less than five influenza-associated adult (≥16 years of age) hospitalizations have been reported by the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network. This is the first report of hospitalization(s) from the network since in week 19 (week ending May 9, 2020) of the 2019-2020 season.

To date this season (August 28 to November 13, 2021), less than five influenza-associated adult (≥16 years of age) hospitalizations have been reported by the CIRN SOS network.

Influenza Strain Characterization

The National Microbiology Laboratory has not yet reported influenza strain characterization results for influenza viruses collected during the 2021-2022 season.

Antiviral Resistance

The National Microbiology Laboratory has not yet reported antiviral resistance results for influenza viruses collected during the 2021-2022 season.

Influenza Vaccine Monitoring

Vaccine monitoring refers to activities related to the monitoring of influenza vaccine coverage and effectiveness.

Vaccine Coverage

Influenza vaccine coverage estimates for the 2021-2022 season are anticipated to be available in February or March 2022.

Vaccine Effectiveness

Influenza vaccine effectiveness estimates for the 2021-2022 season are anticipated to be available in February or March 2022, pending the resumption of community transmission of seasonal influenza.

Provincial and International Surveillance Links

See Influenza surveillance resources

Notes

The data in the FluWatch report represent surveillance data available at the time of writing. All data are preliminary and may change as updates are received.

To learn more about the FluWatch program, see the Overview of influenza monitoring in Canada page.

For more information on the flu, see our Flu (influenza) web page.

We would like to thank all the FluWatch surveillance partners participating in this year's influenza surveillance program.

This report is available on the Government of Canada Influenza webpage.

Ce rapport est disponible dans les deux langues officielles.

Footnote 1

All Provinces and Territories (PTs) participate in FluWatch's outbreak surveillance system. This outbreak system monitors influenza and ILI outbreaks in long-term care facilities, acute care facilities, schools and daycares, remote and/or isolated communities, and facilities categorized as 'other'. Not all reporting PTs report outbreaks in all these settings. All PTs report laboratory confirmed outbreaks in LTCF. Four PTs (NB, NL, NS and YK) report ILI outbreaks in schools and/or daycares and other facilities.

Return to footnote 1 referrer

Footnote 2

Influenza-associated hospitalizations are reported by Alberta, Manitoba, New Brunswick, Newfoundland and Labrador, Northwest Territories, Nova Scotia, Prince Edward Island and Yukon. Only hospitalizations that require intensive medical care are reported by Saskatchewan.

Return to footnote 2 referrer

Page details

Date modified: